- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06933446
Effect of Myofascial Release on Post-Exercise Recovery in Water Polo Athletes
April 15, 2025 updated by: Luis Gustavo Lizi Jorge
Effect of Release of Trigger Points on Functional Capacity, Biomechanical and Physiological Variables in Recovery After Game Simulation in Water Polo Athletes
Objective: To assess the acute effect of a myofascial release protocol applied to the adductor muscles of the thigh on functional, biomechanical, and physiological variables.
Methods: This study is a randomized, double-blind, two-arm crossover clinical trial that will analyze male water polo athletes aged 16 to 25 years recruited from a sports training center in the city of Bauru.
Data related to the following parameters will be collected for the physical evaluation: functional performance, through the jump test; biomechanical, through maximum isometric torque of hip adductors, electromyography of the hip and gluteus medius muscles; and physiological, through the analysis of serum markers of muscle damage and inflammation, and heart rate variability.
After the initial evaluation, the participants will be randomly divided into two groups: intervention group and sham group.
Then, all participants will perform a game simulation.
After the game, the participants will receive the intervention designated for each group.
For the intervention group, a manual therapy protocol will be applied, based on myofascial release in the thigh region that presents trigger points.
For the Sham group, a manual technique, called classic massage, will be applied, with superficial pressure, used to reach only subcutaneous tissues, without acting on muscles and fascia.
This protocol will be repeated at four different times, always after the games.
After a washout week, the participants will change groups and the data collection protocol will be applied again.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
16
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
São Paulo
-
Bauru, São Paulo, Brazil, 17011-160
- Universidade do Sagrado Coração
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Male athletes;
- Age 16 to 25 years old;
- Have at least one year of experience in the sport;
- Perform a training load of at least 10 hours per week in the sport;
- Participate in at least regional level competitions
Exclusion Criteria:
- Have no reports of muscle injury in the thigh in the three months prior to the study,
- Joint injuries in the hip, such as femoroacetabular impingement or tendinopathies of the tendons of the hip muscles or trochanteric, iliopectineal or ischial bursitis diagnosed by a clinician;
- Do not present a drop in -performance for more than four weeks that could characterize the occurrence of non-functional overreaching or signs of overtraining syndrome
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Myofascial Release
|
Massagem clássica, com pressão superficial, utilizada para atingir apenas tecidos subcutâneos, sem que haja ação sobre músculos e fáscias
|
|
Placebo Comparator: Classic Massage
|
A myofascial release protocol, applied to the thigh muscles in post-effort recovery in water polo athletes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Maximum Vertical Jump Test
Time Frame: From enrollment to the end of treatment at 2 weeks
|
From enrollment to the end of treatment at 2 weeks
|
|
|
Maximum Voluntary Isometric Torque of the Hip Adductors
Time Frame: From enrollment to the end of treatment at 2 weeks
|
From enrollment to the end of treatment at 2 weeks
|
|
|
Electromyography of Adductors, Gluteus Medius and Transversus Abdominis
Time Frame: From enrollment to the end of treatment at 2 weeks
|
From enrollment to the end of treatment at 2 weeks
|
|
|
Collection of Serum Markers
Time Frame: From enrollment to the end of treatment at 2 weeks
|
The markers: creatine kinase (CK; Units of Measure= U/L), lactate dehydrogenase (LDH; Units of Measure= UI/L), myoglobin (Myo; Units of Measure= ng/mL), erythrocyte sedimentation rate (ESR; Units of Measure= mm/h), tumor necrosis factor alpha (TNFA; Units of Measure= Å) will be considered for analysis of muscle damage markers and will be determined through specific kits and following the manufacturer's instructions.
|
From enrollment to the end of treatment at 2 weeks
|
|
Heart Rate Variability
Time Frame: From enrollment to the end of treatment at 2 weeks
|
Heart rate variability (HRV) will be collected, at rest, through a non-invasive method used to measure cardiac autonomic control, to assess the autonomic nervous system (ANS), and the RR interval will be recorded by a portable heart rate monitor.
|
From enrollment to the end of treatment at 2 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Effort Control Variables: Subjective Perception of Exertion and Lactate Threshold
Time Frame: From enrollment to the end of treatment at 2 weeks
|
To estimate the intensity of the exercise, the method proposed by Foster (1998) will be used, which suggests multiplying the subjective perception of exertion (RPE) of the session by the total duration of the training session (sRPE), with the results expressed in arbitrary units (u.a.).
To quantify performance during the game, lactate will be collected at the end of each quarter of the game, through blood collections from the earlobe (25 μL) to analyze the peak lactate concentration ([La-]peak) of the effort.
|
From enrollment to the end of treatment at 2 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Rebeca Gasparoto Carmezin, Acadêmica em Fisioterapia, Universidade do Sagrado Coração
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2024
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Study Registration Dates
First Submitted
March 26, 2025
First Submitted That Met QC Criteria
April 15, 2025
First Posted (Actual)
April 18, 2025
Study Record Updates
Last Update Posted (Actual)
April 18, 2025
Last Update Submitted That Met QC Criteria
April 15, 2025
Last Verified
April 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 6.711.962
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fatigue
-
National Taiwan Sport UniversityGrape King Bio Ltd.CompletedEffect of Lactobacillus Plantarum GKK1 Supplementation on Anti-fatigue Health Effects (GKK1-Fatigue)Muscle Fatigue | Sports Performance | Exercise-Induced Fatigue | Fatigue RecoveryTaiwan
-
Bakulev Scientific Center of Cardiovascular SurgeryFoundation for the Support of Physical Culture and Sports BECOME A CHAMPION; Autonomous Non-Profit organization of additional education sports school BECOME A CHAMPIONRecruitingEfficacy, Self | Fatigue, Mental | Fatigue; Muscle, Heart | Fatigue; CombatRussian Federation
-
University of Southern MississippiEnrolling by invitationFatigue, Mental | Fatigue; Muscle, HeartUnited States
-
Akdeniz UniversityCompletedExercise-Induced Fatigue | Forearm Muscle FatigueTurkey (Türkiye)
-
Universita di VeronaUniversity of Southern CaliforniaCompletedDiet, Healthy | Fasting | Fatigue, Mental | Fatigue; Muscle, HeartItaly
-
Supplement Formulators, Inc.Completed
-
Tokat Gaziosmanpasa UniversityNot yet recruitingWork Engagement | Fatigue, Compassion | Quiet QuittingTurkey (Türkiye)
-
Chengdu Sport UniversityNot yet recruiting
-
University of ZurichCompletedVocal FatigueSwitzerland
-
KU LeuvenCompleted
Clinical Trials on Classic Massage
-
University of ValenciaCompletedHamstring ContracturesSpain
-
Jagiellonian UniversityNot yet recruitingMassage | Asthma PatientsPoland
-
Jagiellonian UniversityCompletedMassage | SpirometryPoland
-
Halic UniversityActive, not recruitingCerebral Palsy | Chronic ConstipationTurkey
-
Universidad de AlmeriaCompletedLow Back Pain | Musculoskeletal ManipulationsSpain
-
Okan UniversityNot yet recruiting
-
TC Erciyes UniversityCompleted
-
Ataturk Training and Research HospitalNot yet recruiting
-
Mersin UniversityCompletedFatigue | Interdialytic Weight GainTurkey